• 1
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. Ca Cancer J Clin. 2001;51:1525.
  • 2
    Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer—part I: evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst. 1999;91:101724.
  • 3
    Boyle P. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy. Ann Oncol. 1998;9:12634.
  • 4
    American College of Physicians. Screening for prostate cancer. Ann Intern Med. 1997;126:4804.
  • 5
    U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd Ed. Screening for Prostate Cancer. Baltimore, Md: Williams and Wilkins; 1996:11934.
  • 6
    Ferrini R & Woolf SH. Screening for prostate cancer in American men. Am J Prev Med. 1998;15:814.
  • 7
    American Academy of Family Physicians. AAFP Reference Manual, 1997–1998, Appendix F-Periodic Health Examination. Kansas City, Mo: American Academy of Physicians; 1998:62.
  • 8
    Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. Ca Cancer J Clin. 1993;43:426.
  • 9
    American Urologic Association. Executive Committee Report. Baltimore, Md: American Urologic Association; January 1992.
  • 10
    Von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins M. American Cancer Society guidelines for the early detection of prostate cancer: update 1997. Ca Cancer J Clin. 1997;47:2614.
  • 11
    Smith RA, Von Eschenback AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Ca Cancer J Clin. 2001;51:3851.
  • 12
    Fowler FJ, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:52632.
  • 13
    Hoffman RM, Buller DB, Papenfuss MR, Moon TE. Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prev Med. 1996;12:27781.
  • 14
    McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC. Screening for prostate cancer: a comparison of urologists and primary care physicians. Singapore Med J. 1996;89:8858.
  • 15
    Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice. Arch Fam Med. 1995;4:3115.
  • 16
    Hicks RJ, Hamm RM, Bemben DA. Prostate cancer screening. Arch Fam Med. 1995;4:31722.
  • 17
    Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. Arch Fam Med. 1997;6:4538.
  • 18
    Edlefsen KA, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N. Prostate-specific antigen for prostate cancer screening. Am J Prev Med. 1999;17:8790.
  • 19
    Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women. Does the sex of the physician matter? New Engl J Med. 1993;329:47882.
  • 20
    Franks P & Clancy CM. Physician gender bias in clinical decision-making: screening for cancer in primary care. Med Care. 1993;31:2138.
  • 21
    Sackett DL & Holland WW. Controversy in the detection of disease. Lancet. 1975;2:3579.
  • 22
    Collins MM & Barry MJ. Controversies in prostate cancer screening: analogies to the early lung cancer screening debate. JAMA. 1996;276:19769.
  • 23
    Mauser JS & Kramer S. Epidemiology. Philadelphia: W.B. Saunders Company; 1985:22830.
  • 24
    Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown and Company; 1985:13955.
  • 25
    Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156:13336.
  • 26
    Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11:3429.
  • 27
    Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8:33340.
  • 28
    Frosch DL, Kaplan RM, Felitti V. Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001;16:3918.